1202013-62-4

Basic information

• Product Name: ethyl 4,9-bis(benzyloxy)-11-bromo-2,5,5-trimethyl-1,8-dioxo-1,3,4,5,6,8-hexahydro-2H-pyrido[1,2-a][1,4]diazocine-10-carboxylate
• Synonyms: ethyl 4,9-bis(benzyloxy)-11-bromo-2,5,5-trimethyl-1,8-dioxo-1,3,4,5,6,8-hexahydro-2H-pyrido[1,2-a][1,4]diazocine-10-carboxylate
• CAS NO: 1202013-62-4
• Molecular Weight: 597.506
• Mol File: 1202013-62-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ethyl 4,9-bis(benzyloxy)-11-bromo-2,5,5-trimethyl-1,8-dioxo-1,3,4,5,6,8-hexahydro-2H-pyrido[1,2-a][1,4]diazocine-10-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4,9-bis(benzyloxy)-11-bromo-2,5,5-trimethyl-1,8-dioxo-1,3,4,5,6,8-hexahydro-2H-pyrido[1,2-a][1,4]diazocine-10-carboxylate(1202013-62-4)
• EPA Substance Registry System: ethyl 4,9-bis(benzyloxy)-11-bromo-2,5,5-trimethyl-1,8-dioxo-1,3,4,5,6,8-hexahydro-2H-pyrido[1,2-a][1,4]diazocine-10-carboxylate(1202013-62-4)

Safety Data

• Hazardous Substances Data: 1202013-62-4(Hazardous Substances Data)

Upstream product

• 1202013-60-2 ethyl 3-(benzyloxy)-6-{[2-(benzyloxy)-4-hydroxy-3,3-dimethylbutyl](methyl)aminocarbonyl}-5-bromo-2-oxo-1,2-dihydropyridine-4-carboxylate 
• 1202013-59-9 2-(benzyloxy)-2,2-dimethyl-4-(methylamino)butan-1-ol 
• 1202013-58-8 2-(benzyloxy)-4-hydroxy-N,3,3-trimethylbutanamide 
• 117895-47-3 3-(benzyloxy)-4,4-dimethyldihydrofuran-2(3H)-one 
• 1202013-55-5 5-(benzyloxy)-3-bromo-4-(ethoxycarbonyl)-6-oxo-1,6-dihydropyridine-2-carboxylic acid 
• 1202013-53-3 ethyl 3-(benzyloxy)-5-bromo-6-formyl-2-oxo-1,2-dihydropyridine-4-carboxylate 
• 872462-93-6 3-Benzyloxy-6-formyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid ethyl ester 
• 40876-98-0 sodium 1,4-diethoxy-1,4-dioxobut-2-en-2-olate 
• 267876-32-4 ethyl 3-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-4-carboxylate 
• 267875-78-5 3-benzyloxy-6-methyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid ethyl ester 
• 79-50-5 pantolactone 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 

Downstream Products

• 1202013-63-5 ethyl 4,9-bis(benzyloxy)-2,5,5-trimethyl-1,8-dioxo-11-vinyl-1,3,4,5,6,8-hexahydro-2H-pyrido[1,2-a][1,4]diazocine-10-carboxylate 
• 1202013-18-0 3-(4-fluorobenzyl)-5,10-dihydroxy-9,9,12-trimethyl-9,10,11,12-tetrahydro-3H-pyridazino[4',5':3,4]pyrido[1,2-a][1,4]diazocine-4,6,13(8H)-trione 
• 1202013-64-6 ethyl 4,9-bis(benzyloxy)-11-formyl-2,5,5-trimethyl-1,8-dioxo-1,3,4,5,6,8-hexahydro-2H-pyrido[1,2-a][1,4]diazocine-10-carboxylate 
• 1202013-65-7 5,10-bis(benzyloxy)-3-(4-fluorobenzyl)-9,9,12-trimethyl-9,10,11,12-tetrahydro-3H-pyridazino[4',5':3,4]pyrido[1,2-a][1,4]diazocine-4,6,13(8H)-trione 

Relevant articles and documents

HIV INTEGRASE INHIBITORS

Tricyclic compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: (I) wherein G, T, R1, R2, R3A, R3B, R4A, R4B, R5A, R5B, R6A and R6B are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se (or as hydrates or solvates thereof) or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.